During the past decade, Faculty of Pharmacy conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Faculty of Pharmacy" #1 collaborator was "Nasser Institute For Research and Treatment" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Faculty of Pharmacy" are "Cardiovascular Diseases" (1 trials), "Colorectal Cancer" (1 trials), "Interstitial Lung Disease" (1 trials), "Myocardial Infarction" (1 trials) and "Pharmacogenomic" (1 trials). Many other conditions were trialed in "Faculty of Pharmacy" in a lesser frequency.

Most popular intervention types in "Faculty of Pharmacy" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Atorvastatin 20mg" (1 trials), "Betamethasone, Dexamethasone, Prednisolone" (1 trials), "Bisoprolol" (1 trials), "Clopidogrel" (1 trials) and "Empagliflozin 10 milligram" (1 trials). Other intervention names were less common.

The vast majority of trials in "Faculty of Pharmacy" are 3 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Faculty of Pharmacy". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Faculty of Pharmacy, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Faculty of Pharmacy, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".